talazoparib,temozolomide
pfizer,merck
['sclc', 'talazoparib', 'temozolomide']
are anti-parp a new player in ed-sclc?
why not when looking at these results from dr. goldman et al. from presented in poster discussion #asco22. here are results of talazoparib (in association with temozolomide). 
Head of pulmonology unit @pneumo_LS @CHUdeLyon
Professor of Pulmonology @UnivLyon1
Scientific head @URCOT_lyon & @IFCTlung
#liquidbiopsy~#screening~????